Allied Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
311
-1
-0.3% -$1.02K 0.05% 82
2026
Q1
$287K Hold
312
0.04% 82
2025
Q4
$335K Sell
312
-14
-4% -$13.4K 0.05% 78
2025
Q3
$248K Buy
326
+59
+22% +$43.9K 0.04% 86
2025
Q2
$208K Sell
267
-3
-1% -$2.33K 0.04% 82
2025
Q1
$223K Hold
270
0.04% 82
2024
Q4
$208K Buy
270
+18
+7% +$14.9K 0.04% 77
2024
Q3
$223K Sell
252
-17
-6% -$15.3K 0.04% 71
2024
Q2
$243K Hold
269
0.06% 62
2024
Q1
$209K Buy
+269
New +$191K 0.05% 65

Other funds holding LLY

Allied Investment Advisors's LLY Position: Q2 2026 in Review

Allied Investment Advisors reduced its Eli Lilly (LLY) stake by 0.32% in Q2 2026, selling an estimated $1.02K and leaving 311 shares worth $374K. The position accounts for 0.05% of the portfolio, ranked #82.

Allied Investment Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Allied Investment Advisors held 311 shares of Eli Lilly worth $374K as of Q2 2026.
  • Allied Investment Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.05% of Allied Investment Advisors's portfolio in Q2 2026, its #82 holding.
  • Allied Investment Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Allied Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.